May 3, 2018 / 8:14 PM / 18 days ago

BRIEF-Cti Biopharma Reports Q1 EPS Loss Per Share Of $0.08

May 3 (Reuters) - CTI Biopharma Corp:

* CTI BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 REVENUE $10.5 MILLION VERSUS $800,000

* AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $104.6 MILLION, COMPARED TO $43.2 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below